Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

A case of primary HIV type 1 and cytomegalovirus coinfection presenting with widespread clinical disease.

Kim JY, Singer EJ, Bonelli L, Klausner JD.

J Int Assoc Provid AIDS Care. 2014 May-Jun;13(3):196-9. doi: 10.1177/2325957413519289. Epub 2014 Jan 29.

2.

Cytomegalovirus infection in HIV-infected versus non-infected infants and HIV disease progression in Cytomegalovirus infected versus non infected infants early treated with cART in the ANRS 12140-Pediacam study in Cameroon.

Kfutwah AK, Ngoupo PA, Sofeu CL, Ndongo FA, Guemkam G, Ndiang ST, Owona F, Penda IC, Tchendjou P, Rouzioux C, Warszawski J, Faye A, Tejiokem MC.

BMC Infect Dis. 2017 Mar 23;17(1):224. doi: 10.1186/s12879-017-2308-x.

3.

Acute retroviral syndrome complicated by cytomegalovirus and hepatitis A coinfection.

Nguyen C, Lebel F.

J Infect Dis. 1991 Jul;164(1):219-20. No abstract available.

PMID:
1647425
4.

Hepatitis B and HIV co-infection is still treated using lamivudine-only antiretroviral therapy combination in Uganda.

Ocama P, Seremba E, Apica B, Opio K.

Afr Health Sci. 2015 Jun;15(2):328-33. doi: 10.4314/ahs.v15i2.4.

5.
6.

The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection.

Mehta SH, Thomas DL, Torbenson M, Brinkley S, Mirel L, Chaisson RE, Moore RD, Sulkowski MS.

Hepatology. 2005 Jan;41(1):123-31.

PMID:
15619237
7.

HIV type 1 and cytomegalovirus coinfection in the female genital tract.

Lurain NS, Robert ES, Xu J, Camarca M, Landay A, Kovacs AA, Reichelderfer PS.

J Infect Dis. 2004 Aug 1;190(3):619-23. Epub 2004 Jun 30.

8.

Acute cytomegalovirus pneumonia and hepatitis presenting during acute HIV retroviral syndrome.

Hong KW, Kim SI, Kim YJ, Wie SH, Kim YR, Yoo JH, Han NI, Kang MW.

Infection. 2011 Apr;39(2):155-9. doi: 10.1007/s15010-010-0074-4. Epub 2011 Jan 19.

PMID:
21246249
9.

Impact of seminal cytomegalovirus replication on HIV-1 dynamics between blood and semen.

Gianella S, Mehta SR, Strain MC, Young JA, Vargas MV, Little SJ, Richman DD, Kosakovsky Pond SL, Smith DM.

J Med Virol. 2012 Nov;84(11):1703-9. doi: 10.1002/jmv.23398.

10.

Seroprevalence of CMV, HSV-2 and HBV among HIV-Infected Malawian Children: A Cross-sectional Survey.

Varo R, Buck WC, Kazembe PN, Phiri S, Andrianarimanana D, Weigel R.

J Trop Pediatr. 2016 Jun;62(3):220-6. doi: 10.1093/tropej/fmv105. Epub 2016 Feb 15.

11.

CD8 T-Cell Expansion and Inflammation Linked to CMV Coinfection in ART-treated HIV Infection.

Freeman ML, Mudd JC, Shive CL, Younes SA, Panigrahi S, Sieg SF, Lee SA, Hunt PW, Calabrese LH, Gianella S, Rodriguez B, Lederman MM.

Clin Infect Dis. 2016 Feb 1;62(3):392-6. doi: 10.1093/cid/civ840. Epub 2015 Sep 23.

12.

Ocular manifestations of HIV infection.

Jabs DA.

Trans Am Ophthalmol Soc. 1995;93:623-83.

13.

Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials.

Nelson M, Amaya G, Clumeck N, Arns da Cunha C, Jayaweera D, Junod P, Li T, Tebas P, Stevens M, Buelens A, Vanveggel S, Boven K; ECHO and THRIVE Study Groups.

J Antimicrob Chemother. 2012 Aug;67(8):2020-8. doi: 10.1093/jac/dks130. Epub 2012 Apr 24.

14.

Viral coinfections among African children infected with human immunodeficiency virus type 1.

Chakraborty R, Rees G, Bourboulia D, Cross AM, Dixon JR, D'Agostino A, Musoke R, Boshoff C, Rowland-Jones SL, Klenerman P.

Clin Infect Dis. 2003 Apr 1;36(7):922-4. Epub 2003 Mar 19.

PMID:
12652394
15.

Distribution and determinants of cytomegalovirus induced end organ disease/s among people living with HIV/AIDS in a poor resource setting: observation from India.

Chakraborty A, Mahapatra T, Mahapatra S, Ansari S, Siddhanta S, Banerjee S, Banerjee D, Sarkar RN, Guha SK, Chakraborty N.

PLoS One. 2015 Feb 13;10(2):e0117466. doi: 10.1371/journal.pone.0117466. eCollection 2015.

16.

Impact of hepatitis C virus on HIV response to antiretroviral therapy in Nigeria.

Agbaji O, Thio CL, Meloni S, Graham C, Muazu M, Nimzing L, Idoko J, Sankalé JL, Ekong E, Murphy R, Kanki P, Hawkins C.

J Acquir Immune Defic Syndr. 2013 Feb 1;62(2):204-7. doi: 10.1097/QAI.0b013e31827ce536.

17.

Acute cytomegalovirus infection is associated with increased frequencies of activated and apoptosis-vulnerable T cells in HIV-1-infected infants.

Slyker JA, Rowland-Jones SL, Dong T, Reilly M, Richardson B, Emery VC, Atzberger A, Mbori-Ngacha D, Lohman-Payne BL, John-Stewart GC.

J Virol. 2012 Oct;86(20):11373-9. Epub 2012 Aug 8.

18.

The Association of Human Cytomegalovirus with Biomarkers of Inflammation and Immune Activation in HIV-1-Infected Women.

Lurain NS, Hanson BA, Hotton AL, Weber KM, Cohen MH, Landay AL.

AIDS Res Hum Retroviruses. 2016 Feb;32(2):134-43. doi: 10.1089/AID.2015.0169. Epub 2015 Oct 22.

19.

Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection.

Freeman ML, Lederman MM, Gianella S.

Curr HIV/AIDS Rep. 2016 Feb;13(1):10-9. doi: 10.1007/s11904-016-0297-9. Review.

20.

[Diagnosis and treatment of eye diseases associated with HIV infection and AIDS].

Geng S, Ye JJ, Liu LQ, Xu HY, Wang WW, Wang SR.

Zhonghua Yan Ke Za Zhi. 2009 Dec;45(12):1093-8. Chinese.

PMID:
20193432

Supplemental Content

Support Center